updated 2/28/2008 11:31:57 AM ET 2008-02-28T16:31:57

The Food and Drug Administration on Thursday approved AstraZeneca's Nexium to treat chronic heartburn in children.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

The agency cleared two formulations of the drug — liquid and capsule — for short-term use in children one to 11 years old. According to the drug's new labeling, children should not take the drug for more than eight weeks.

FDA previously approved Nexium in the U.S. to treat heartburn in adults and adolescents.

Nexium was the world's second-best selling drug in 2006, according to health care research firm IMS Health.

The drug is part of a family of acid-reducing drugs known as proton pump inhibitors.

Copyright 2008 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments